Gene Query: TMEM141

Dataset Description Geneva Score
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 42.44
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 34.2
RNA-seq in transgenic cells 30.26
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 28.53
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 25.74
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 25.53
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 25.53
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 25.1
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 24.16
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 23.78
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 23.78
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 23.74
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 22.59
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 22.19
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 22.14
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 21.57
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 20.65
Differetially expressed genes after hTR overexpression in U2OS cells 20.17
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 19.97
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 19.97
Single-nucleotide-resolution mapping of HBV promoters using CAGE 19.97
Energy Metabolism during Anchorage-Independence 19.41
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 18.93
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 18.84
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 18.48
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 18.08
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 17.7
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 17.7
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 17.53
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 16.98
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 16.98
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 16.78
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 16.22
Ectoderm specification of H1 human embryonic stem cells 15.63
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 15.29
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 14.96
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 14.73
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 14.67
Regulation of highly expressed hCINAP on translatome 14.66
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 14.66
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 14.66
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 14.42
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 14.4
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 14.3
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 14.3
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 14.2
Global analyses of the effect of different cellular contexts on microRNA targeting 14.2
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 14.13
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 14.11
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 13.78
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 13.74
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 13.74
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 13.32
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 13.06
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 13.05
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 12.99
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 12.39
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 12.38
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 12.3
Lipid degradation promotes prostate cancer cell survival 11.78
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 11.72
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 11.68
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 11.57
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 11.56
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 11.42
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 11.42
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 11.34
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 11.34
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 11.1
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 11.09
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 10.98
Dynamic reorganization of nuclear architecture during human cardiogenesis 10.85
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 10.85
Lysine benzoylation is a novel histone mark 10.77
Lysine benzoylation is a novel histone mark [RNA-seq] 10.77
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 10.72
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 10.67
Active translatome profiling with RiboLace in MCF7 cells 10.46
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 10.43
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 10.42
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 10.27
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 10.24
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 10.21
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 10.14
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 9.5
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 9.47
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 9.47
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 9.4
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 9.35
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 9.32
Mechanistic Model-Guided Study of Embryonic Morphogenesis 9.31
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 9.3
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 9.22
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 9.22
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 9.12
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 9.09
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 9.09
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 9.02
Identifying the molecular mode of action of itraconazole in colorectal cancer 9.0
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 8.86
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 8.86
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 8.78
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 8.74
Total RNA sequencing of APC mutant and wt colonic organoids 8.71
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 8.7
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 8.58
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 8.58
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 8.56
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 8.51
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 8.5
Dtx3L and Androgen Signaling in Prostate Cancer 8.45
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 8.4
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 8.39
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.38
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 8.36
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 8.36
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 8.33
Identification of HOXB13 target genes responsive to BET inhibitors 8.29
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 8.24
Survival of pancreatic cancer cells lacking KRAS function 8.22
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 8.22
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 8.2
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 8.17
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 8.15
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 8.09
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 8.09
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 8.09
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 8.02
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 8.01
RNAseq analysis of ESRP regulated splicing events in prostate cancer 7.99
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 7.84
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 7.76
RNAseq of cell lines with knocked in ESR1 mutations 7.64
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 7.63
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 7.63
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 7.57
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 7.57
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 7.56
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 7.56
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 7.53
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 7.48
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 7.48
Postnatal lipids drive hepatocyte maturation 7.44
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 7.44
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 7.35
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 7.32
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 7.31
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 7.24
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 7.22
T47D RNA-seq and ChrRNA-seq data 7.2
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 7.2
Generating Patterned Kidney Organoids for Studying Development and Diseases 7.16
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 7.15
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 7.12
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 7.11
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 7.09
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 7.04
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 7.04
An optimization system for isolating and sequencing of single human colon cancer cells 7.02
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 6.96
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 6.95
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 6.94
TT-Seq captures the human transient transcriptome 6.92
Transcriptome profiling of Normal and Cancerous Prostate Cells 6.82
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 6.81
Nutritional control of protein translation 6.8
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 6.79
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 6.79
Gene expression patterns define the hepatocyte-like cells derived by different strategies 6.79
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 6.74
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 6.72
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 6.72
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.71
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 6.71
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 6.7
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 6.67
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 6.57
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 6.5
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 6.5
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 6.48
RNA-seq analyses of human prostate cancer cells 6.43
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 6.39
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 6.37
The regulartory role of ZCCHC24 in splicing machinery 6.36
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 6.36
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 6.33
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 6.33
Comprehensive comparative analysis of 5’ end RNA sequencing methods 6.27
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 6.27
EWSR1 influences alternative splicing through direct and indirect mechanisms 6.27
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 6.27
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6.27
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 6.1
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 6.08
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 5.99
RNA-seq of IL-4 stimulated human keratinocytes 5.96
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 5.96
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 5.96
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 5.9
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 5.88
RNA-seq analysis of breast cancer 5.86
RNA-seq analysis and shRNA screen of breast cancer 5.86
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 5.78
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 5.77
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 5.77
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 5.73
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 5.59
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 5.56
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 5.55
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 5.55
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 5.53
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 5.52
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 5.49
Global analysis of enhancer targets: Mosaic-seq 5.42
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 5.39
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 5.39
KLF6-dependent transcription in renal cancer cells 5.37
Nrf2 regulated genes in A549 cells 5.23
Identification of Nrf2 regulated genes by RNA sequencing 5.23
Comparing gene expression in iPSC derived RPE from control and AMD donors 5.22
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 5.21
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 5.21
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 5.11
Neonatal and adult human testis defined at the single-cell level 5.1
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 5.07
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 5.07
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 5.04
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 5.04
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 5.04
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 5.03
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 5.0
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 4.97
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 4.97
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 4.94
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 4.93
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 4.91
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 4.9
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 4.88
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 4.86
RNA-seq analysis of the human fetal kidney. 4.84
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 4.83
Tracking distinct RNA populations using efficient and reversible covalent chemistry 4.8
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.78
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.78
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 4.78
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 4.78
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 4.76
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 4.76
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 4.69
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 4.68
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 4.64
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 4.64
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 4.63
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 4.61
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 4.56
Cerebellar differentiation in Ataxia-Telangiectasia 4.54
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 4.51
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 4.47
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 4.43
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 4.42
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 4.41
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 4.39
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 4.39
The effect of insulin on mRNA transcription of human pluripotent stem cells 4.37
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 4.36
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 4.36
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 4.35
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 4.35
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 4.31
The transcriptome effect of overexpressing EZH2 in MCF7 4.3
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.29
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 4.27
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 4.24
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 4.21
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 4.21
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 4.19
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 4.19
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 4.19
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 4.19
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 4.17
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 4.12
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 4.12
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 4.12
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 4.11
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 4.02
Gene expression profile in breast cancer cell lines using RNA sequencing 3.94
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 3.94
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 3.92
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 3.91
Gene expression profile of multiple myeloma cell lines treated with CB-5083 3.9
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 3.88
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 3.81
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 3.8
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 3.77
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 3.71
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 3.71
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 3.71
Gene expression changes due to PARP knockdown in human cells 3.69
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 3.68
RNA seq analysis of human Fetal and adult derived Enterospheres 3.57
Expression profiles of the four human major ectodermal lineages 3.55
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 3.52
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 3.52
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 3.48
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 3.42
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 3.42
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 3.41
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 3.4
ETV7 and interferon response 3.4
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.37
Copper Regulation of HIF-1 Transcription Activity 3.36
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 3.36
RNA-seq differential expression studies: more sequence, or more replication? 3.35
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.35
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.35
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 3.29
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 3.22
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 3.15
AUF-1 affected genes in human skin cells 3.13
Exploring ILF2 regulatory genes by next-generation sequencing 3.11
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 3.09
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.09
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 3.05
HNRNPM-regulated splicing dependencies in prostate cancer 3.03
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 3.03
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 2.97
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 2.97
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 2.95
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 2.93
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 2.92
Hepatitis C virus functionally sequesters miR-122 2.91
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 2.91
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 2.86
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 2.86
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 2.84
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.78
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 2.76
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 2.76
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 2.75
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.73
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 2.67
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 2.66
RNA editing in nascent RNA affects pre-mRNA splicing 2.64
NR2F2 study 2.62
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 2.62
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 2.61
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 2.61
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 2.6
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 2.56
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 2.56
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 2.55
HEK293 TFAM Knockout Expression Study 2.54
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 2.53
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 2.53
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 2.53
Changes in human endometrial gland transcriptome over the window of implantation 2.51
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 2.51
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.51
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 2.51
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 2.5
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 2.5
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 2.49
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 2.44
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 2.43
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 2.43
Effect of CHKA knockdown on C4-2 cell transcriptome 2.41
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 2.37
Loss of endometrial plasticity in recurrent pregnancy loss 2.37
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 2.37
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.36
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 2.31
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 2.25
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.18
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.18
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 2.17
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 2.17
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 2.15
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 2.15
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 2.14
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 2.13
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 2.12
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 2.12
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 2.09
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 2.06
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 2.06
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 2.05
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 2.05
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.04
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.04
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 2.01
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.97
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.95
Gene expression analysis of human adenomas. 1.92
MCF-7 as a model for functional analysis of breast cancer risk variants 1.91
Chromatin landscape of human visceral and subcutaneous adipocytes 1.9
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.87
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.87
Single-cell analysis of human kidney organoids 1.87
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 1.86
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 1.85
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.83
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.77
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 1.77
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 1.7
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 1.69
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 1.69
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 1.68
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.67
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 1.64
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 1.64
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 1.58
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 1.58
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 1.54
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 1.54
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 1.54
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 1.54
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 1.54
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.49
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.42
miRNAs affected by antagomiR-17 treatment 1.41
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.36
SRSF1 role in cellular gene expression and splicing 1.32
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 1.3
Effect of ILF3 on translation during homeostasis and the antiviral response 1.26
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 1.24
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 1.24
Gene expression profiling of papillary thyroid cancer from central and invasive regions 1.22
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 1.22
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 1.19
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 1.18
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 1.18
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.15
RNA-Seq of PRMT1 overexpression ECA109 cells 1.12
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 1.11
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.1
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 1.09
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 1.06
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 1.04
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 1.01
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.99
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.98
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 0.97
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.92
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 0.91
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 0.91
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 0.89
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.87
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.84
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.79
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.76
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.71
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.71
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.67
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.66
Impact on erythroid progenitor type on erythroid differntiation 0.65
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.63
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.6
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.58
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.58
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.58
Effect of PBK knockdown on C4-2 cell transcriptome 0.57
The role of the Calcium-Sensing receptor in colorectal cancer 0.56
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.51
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.51
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.48
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.47
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.47
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.46
CDK4/6 inhibitor resistance in prostate cancer 0.46
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 0.42
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.38
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 0.38
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 0.37
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.36
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 0.33
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 0.31
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.3
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.29
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.29
RNA-seq of cancer cell lines treated with T-025 0.26
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.26
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.24
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.24
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.24
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.23
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.14
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.14
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.14
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.14
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.11
The circadian transcriptional landscape in primary human mammary epithelial cells 0.1
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.08
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.08
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.07
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.06
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.02
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.02
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 0.02
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 0.02
Engineering Patient-Specific Tissue Implants 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation